AVNT Stock Analysis — Avient Corporation
Sector: Specialty Chemicals
AI Verdict
You're paying a low price for explosive growth, but the story is fragile if Avient can't deliver on the 244.8% EPS ramp baked into the forward P/E.
Competitive Moat
Avient specializes in high-performance polymer formulations and colorant solutions for demanding end-markets like healthcare and packaging, where switching costs and regulatory approvals create customer stickiness. Its technical expertise and proprietary formulations make it hard for competitors to displace Avient in critical applications.
Summary
A projected 244.8% jump in earnings is driving a dramatic drop in forward P/E for this specialty chemicals player.
Where It Stands
AVNT trades at 11.7x next year's earnings, a steep discount to the specialty chemicals sector median of ~20x, with analysts forecasting 244.8% EPS growth after a flat 0.6% revenue year.
Key Metrics
- Trailing P/E: 40.3x
- Forward P/E: 11.7x
- PEG Ratio: 0.16
- Earnings Growth: +2.4%
- Revenue Growth: +0.0%
- Dividend Yield: 0.03%
- 52-Week High: $44.85
- 52-Week Low: $27.48
Analyst Consensus
11 Buy · 3 Hold · 0 Sell (14 analysts)
Bull Case
The 244.8% forward EPS growth expectation justifies the low 11.7x forward P/E, making the stock cheap for the growth you're getting if execution matches forecasts.
Bear Case
If the 244.8% EPS surge fails to materialize, the 40.3x trailing P/E leaves plenty of room for the stock to fall as the market re-rates it closer to the sector's 20x norm.
Catalyst to Watch
Quarterly earnings delivery is the key catalyst; any sign that the triple-digit EPS growth is off track could trigger a sharp multiple reset.